APA (7th ed.) Citation

Kozal, M. J., Lupo, S., DeJesus, E., Molina, J., McDonald, C., Raffi, F., . . . Team, T. S. S. (2012). A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results. HIV clinical trials, 13(3), 119. https://doi.org/10.1310/hct1303-119

Chicago Style (17th ed.) Citation

Kozal, Michael J., et al. "A Nucleoside- and Ritonavir-sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-naïve HIV-infected Patients: SPARTAN Study Results." HIV Clinical Trials 13, no. 3 (2012): 119. https://doi.org/10.1310/hct1303-119.

MLA (9th ed.) Citation

Kozal, Michael J., et al. "A Nucleoside- and Ritonavir-sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-naïve HIV-infected Patients: SPARTAN Study Results." HIV Clinical Trials, vol. 13, no. 3, 2012, p. 119, https://doi.org/10.1310/hct1303-119.